☆ 4.7 Article

Controversies and challenges regarding the impact of radiation therapy on survival

ANNALS OF ONCOLOGY (2013)

Journal

ANNALS OF ONCOLOGY

Volume 24, Issue 1, Pages 38-46

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/annonc/mds217

Keywords

chemotherapy; local control; radiation therapy; survival; targeted agent

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

Novel irradiation techniques and radiosensitizing strategies revealed their interest for improving the antitumor efficacy of radiation therapy (RT) and thus for reducing locoregional failures. We analyzed the relevance of these strategies with regard to their impact on survival. The examples of the targeted molecular agent cetuximab and dose intensification in head and neck and lung cancer show that this benefit in local control is associated with a survival benefit. Large meta-analyses comparing sequential versus concurrent chemoradiation have also highlighted that improvement in local control is a major contributor to the survival benefit observed in chemoradiation trials. This close link between local control and survival encourages us to pursue our efforts to further improve the efficacy of RT. In some cases, the survival benefit afforded by radiotherapy is however marginal. The better understanding of the impact of local control on overall survival might allow optimization of clinical trials designs.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Medicine, Research & Experimental

A Redox-Activatable and Targeted Photosensitizing Agent to Deliver Doxorubicin for Combining Chemotherapy and Photodynamic Therapy

Jun Yin, Chengcheng Ouyang, Shuwei Shen, Yaxin Zhou, Guoyi He, Heng Zhang, Kai Zhou, Guoguang Chen, Lili Ren

Summary: In this study, a smart nano drug delivery platform was designed and synthesized for the combination of chemotherapy and photodynamic therapy in cancer treatment. The nanoparticles exhibited good stability and hemocompatibility, and showed higher antitumor activity and lower systemic toxicity under laser irradiation.

MOLECULAR PHARMACEUTICS (2022)

Add to Collection

Article Chemistry, Physical

Cerenkov radiation induced chemo-photodynamic therapy using ROS-responsive agent

Shiliang Zhu, Ke Li, Shuai Qin, Jianguo Lin, Ling Qiu

Summary: Traditional photodynamic therapy (PDT) using external light source has poor tissue penetration. Cerenkov radiation (CR) can serve as an internal light source to activate photosensitizers. However, the outcomes of CR-induced PDT (CR-PDT) are limited by the weakness of CR emission. This study presents a new strategy using a ROS-responsive Chemo-PDT agent to improve the outcomes of CR-PDT.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2023)

Add to Collection

Review Oncology

Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside

Icro Meattini, Lorenzo Livi, Nicla Lorito, Carlotta Becherini, Marina Bacci, Luca Visani, Alessandra Fozza, Liliana Belgioia, Mauro Loi, Monica Mangoni, Matteo Lambertini, Andrea Morandi

Summary: Significant progress has been made in precision medicine for breast cancer patients through the development of molecular targeted therapies. The combination of these therapies with radiation therapy has the potential for synergistic effects, but safety concerns should be taken into account. Currently, there is limited evidence on the quality assurance of radiation therapy and safety reports in the context of new drugs, especially in advanced cases. Preclinical studies could contribute to effectively combining radiation and targeted therapies in breast cancer.

CANCER TREATMENT REVIEWS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Photosensitive EGFR-Targeted Nanocarriers for Combined Photodynamic and Local Chemotherapy

Elena de las Heras, M. Lluisa Sagrista, Montserrat Agut, Santi Nonell

Summary: This study explores the use of actively-targeted chemo-photo-nanocarriers to improve the localization of chemotherapy drugs in tumor cells. The results show that the attachment of high concentrations of doxorubicin to cetuximab-IRDye700DX-mesoporous silica nanoparticles yields efficient and selective photokilling of EGFR-expressing cells, without any dark toxicity.

PHARMACEUTICS (2022)

Add to Collection

Review Immunology

Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches

Emily P. P. Vonderhaar, Michael B. B. Dwinell, Brian T. T. Craig

Summary: Surgery or radiation therapy is commonly used for pediatric solid tumors, but they may not effectively treat distant metastatic disease. The body's response to these local treatment modalities may suppress immune response and negatively impact patient outcomes. Recent evidence suggests that immune responses to surgery or radiation can be therapeutically modulated to enhance anti-tumor immunity and prevent tumor growth. Understanding the tumor-specific immunology and immune responses to surgery and radiation is crucial for effectively modulating perioperative immunity and achieving successful anti-tumor outcomes.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Oncology

Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography

Anjali L. Saripalli, Brian Lee, William Adams, Niranjan Bhandare, Bhanu P. Venkatesulu, Ryan K. Yoo, Jennifer Price, Grant A. Harmon, Alec M. Block, Nicholas Friedman, Matthew M. Harkenrider, Erica J. Major, William Small Jr, Robert H. Wagner, James S. Welsh, Abhishek A. Solanki

Summary: This study used molecular imaging to identify the anatomical locations of para-aortic (PA) nodal metastases in prostate cancer, and developed guidelines for delineating the optimal clinical target volume (CTV). The findings provide valuable information for radiation therapy planning in patients with prostate cancer.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Add to Collection

Article Medicine, General & Internal

Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma A SEER population-based study

Yan Lu, Jianfeng Hua, Fengqin Yan, Chuner Jiang, Yongfeng Piao, Zhimin Ye, Zhenfu Fu, Haitao Jiang, Fangzheng Wang, Yangming Jiang

Summary: In elderly patients aged 65 years and older with nasopharyngeal carcinoma, the combination of radiation therapy and chemotherapy resulted in longer overall survival compared to radiation therapy alone. Additionally, this combination treatment showed a better correlation with overall survival and cancer-specific survival in patients with stage T3 or N2 or stage III.

MEDICINE (2021)

Add to Collection

Article Oncology

Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases

Laura Uder, Marcel Nachbar, Sarah Butzer, Jessica Boldt, Sabrina Baumeister, Michael Bitzer, Alfred Koenigsrainer, Thomas Seufferlein, Ruediger Hoffmann, Sergios Gatidis, Konstantin Nikolaou, Daniel Zips, Daniela Thorwarth, Cihan Gani, Simon Boeke

Summary: This study reported on the use of online magnetic resonance guided radiotherapy for liver metastases. The results showed high local control rates and improvements in patient reported outcome measures and quality of life. Further prospective trials are ongoing to define the patient population that will benefit most from this online adaptive workflow.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Otorhinolaryngology

Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study

Zhen-Chong Yang, Mei-Juan Luo, Xue-Song Sun, Li-Ting Liu, Qiu-Yan Chen, Hai-Qiang Mai, Shan-Shan Guo

Summary: This study evaluated the suitability of radiation therapy and liver local therapy for patients with lmNPC. The results showed that radiation therapy may be beneficial for lmNPC patients regardless of the tumor response after chemotherapy.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Add to Collection

Article Urology & Nephrology

Definitive local therapy for T4 prostate cancer associated with improved local control and survival

Lauren M. Andring, Ibrahim Abu-Gheida, Tharakeswara Bathala, Alison K. Yoder, Gohar S. Manzar, J. Alberto Maldonado, Steven J. Frank, Seungtaek Choi, Quynh-Nhu Nguyen, Karen Hoffman, Sean Eric McGuire, Henry Mok, Ana Aparicio, Brian F. Chapin, Chad Tang

Summary: This study aimed to evaluate patients with clinical (c)T4 prostate cancer, who often have locally advanced disease and obstructive symptoms causing significant morbidity and mortality. The study analyzed whether receiving definitive local therapy influenced symptomatic and oncological outcomes. The results showed that definitive local therapy for cT4 prostate cancer was associated with improved symptomatic outcomes and survival.

BJU INTERNATIONAL (2023)

Add to Collection

Article Oncology

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience

Alexander F. Bagley, Ethan B. Ludmir, Anirban Maitra, Bruce D. Minsky, Grace Li Smith, Prajnan Das, Albert C. Koong, Emma B. Holliday, Cullen M. Taniguchi, Matthew H. G. Katz, Eric P. Tamm, Robert A. Wolff, Michael J. Overman, Shivani Patel, Michael P. Kim, Ching-Wei D. Tzeng, Naruhiko Ikoma, Manoop S. Bhutani, Eugene J. Koay

Summary: NBTXR3 has shown clinical activity in PDAC patients who are not eligible for surgery. Local endoscopic delivery of NBTXR3 followed by radiation therapy demonstrated feasibility and tolerance in treating pancreatic cancer, resulting in tumor stability.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2022)

Add to Collection

Article Oncology

A Trimodality, Four-Step Treatment including Chemotherapy, Pleurectomy/Decortication and Radiotherapy in Early-Stage Malignant Pleural Mesothelioma: A Single-Institution Retrospective Case Series Study

Giovanni Vicidomini, Carminia Maria Della Corte, Antonio Noro, Raimondo Di Liello, Salvatore Cappabianca, Alfonso Fiorelli, Valerio Nardone, Gaetana Messina, Giuseppe Viscardi, Angelo Sangiovanni, Riccardo Monti, Marina Accardo, Floriana Morgillo, Fortunato Ciardiello, Renato Franco, Mario Santini

Summary: Multimodality treatment can improve the outcome of patients with malignant pleural mesothelioma. A case series of 17 patients treated with a combination of induction chemotherapy, surgery, adjuvant radiotherapy, and chemotherapy showed promising results, with a median overall survival of 32.1 months and a median progression-free survival of 23.7 months.

CANCERS (2022)

Add to Collection

Article Oncology

Second Malignant Neoplasms in Patients With Rhabdomyosarcoma

Hongnan Zhen, Zhikai Liu, Hui Guan, Jiabin Ma, Wenhui Wang, Jing Shen, Zheng Miao, Fuquan Zhang

Summary: This study describes the risk factors associated with the development of second malignant neoplasms (SMN) in patients with rhabdomyosarcoma (RMS), which is helpful for the personalized screening of high-risk RMS patients.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Reduced Wide Local Excision Margins are Associated with Increased Risk of Relapse and Death from Merkel Cell Carcinoma

Neal Andruska, Lily Mahapatra, Randall J. Brenneman, Jason T. Rich, Brian C. Baumann, Leigh Compton, Wade L. Thorstad, Mackenzie D. Daly

Summary: The size of excision margins in patients with Merkel cell carcinoma can impact recurrence and survival rates, with larger margins associated with better outcomes. Close or positive pathologic margins were linked to a higher risk of relapse and death. It is important to consider wider excision margins, especially in populations with lower rates of adjuvant radiation.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Surgery

Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal Cancer

Byung Min Lee, Jee Suk Chang, Woong Sub Koom, Hwa Kyung Byun, Han Sang Kim, Seung-Hoon Beom, Caleb Oh, Young Joo Suh, Joong Bae Ahn, Sang Joon Shin, Byung Jo Park, Seong Yong Park

Summary: This study aimed to assess the effect of local ablative therapy (LAT) on overall survival in patients with lung metastases from colorectal cancer (CRC). The results showed that patients treated with LAT had significantly higher survival rates compared to those treated with systemic therapy alone.

ANNALS OF SURGERY (2023)

Add to Collection

Review Cell Biology

Chronic Inflammation and Radiation-Induced Cystitis: Molecular Background and Therapeutic Perspectives

Carole Helissey, Sophie Cavallero, Clement Brossard, Marie Dusaud, Cyrus Chargari, Sabine Francois

Summary: Radiation cystitis is a potential complication of pelvic cancer treatment, with unclear clinical management and underlying pathophysiology. The lack of prospective and randomized trials makes establishing therapeutic strategies difficult. The immunopathological processes and fibrotic process of radiation cystitis, as well as potential therapeutic approaches focusing on the interaction between mesenchymal stromal cells and macrophages, are key points of discussion.

CELLS (2021)

Add to Collection

Review Oncology

Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review

Sophie Bockel, Sophie Espenel, Roger Sun, Isabelle Dumas, Sebastien Gouy, Philippe Morice, Cyrus Chargari

Summary: Reirradiation using three-dimensional image-guided brachytherapy (3D-IGBT) shows promise as an alternative to salvage surgery for inoperable patients with local recurrence in gynecological malignancies occurring in a previously irradiated field, although long-term toxicities may be high in some cases. Patients in this situation should be referred to highly experienced expert centers for treatment. Centralization of data and large-scale multicentric international prospective trials are needed to improve local control while minimizing toxicities.

CANCERS (2021)

Add to Collection

Article Oncology

Pulsed Dose Rate Brachytherapy of Lip Carcinoma: Clinical Outcome and Quality of Life Analysis

Radouane El Ayachy, Roger Sun, Kanta Ka, Adrien Laville, Anne-Sophie Duhamel, Anne Tailleur, Isabelle Dumas, Sophie Bockel, Sophie Espenel, Pierre Blanchard, Yungan Tao, Stephane Temam, Antoine Moya-Plana, Christine Haie-Meder, Cyrus Chargari

Summary: The study confirms that excellent local control rate is achieved with PDR brachytherapy as treatment of lip carcinoma, with very limited late side effects and satisfactory functional outcomes.

CANCERS (2021)

Add to Collection

Article Oncology

Image-Guided Adaptive Brachytherapy (IGABT) for Primary Vaginal Cancer: Results of the International Multicenter RetroEMBRAVE Cohort Study

Henrike Westerveld, Maximilian P. Schmid, Remi A. Nout, Cyrus Chargari, Bradley R. Pieters, Carien L. Creutzberg, Alina Sturdza, Jacob C. Lindegaard, Zdenko van Kesteren, Renaud Mazeron, Nicole Nesvacil, Lars U. Fokdal

Summary: This large retrospective multicenter study demonstrated that image-guided adaptive brachytherapy (IGABT) for primary vaginal cancer achieves high local control with acceptable morbidity. Results compare favorably with two-dimensional radiograph-based brachytherapy, highlighting the importance of IGABT in the treatment of vaginal cancer.

CANCERS (2021)

Add to Collection

Article Oncology

Brachytherapy for the Conservative Treatment of Female Peri-Urethral Carcinoma

Mickael Andraud, Manon Kissel, Roger Sun, Elie Rassy, Sophie Espenel, Samir Achkar, Philippe Morice, Christine Haie-Meder, Sebastien Gouy, Cyrus Chargari

Summary: Treatment of peri-urethral gynecological tumors presents challenges, and interstitial brachytherapy combined with external radiotherapy shows high local control probability as a conservative treatment option. This treatment strategy aims to spare patients from surgery-related morbidity while effectively managing the tumors.

CANCERS (2022)

Add to Collection

Article Oncology

Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists

Markus Glatzer, Kari Tanderup, Angeles Rovirosa, Lars Fokdal, Claudia Ordeanu, Luca Tagliaferri, Cyrus Chargari, Vratislav Strnad, Johannes Athanasios Dimopoulos, Barbara Segedin, Rachel Cooper, Esten Sondrol Nakken, Primoz Petric, Elzbieta van der Steen-banasik, Kristina Lossl, Ina M. Jurgenliemk-Schulz, Peter Niehoff, Ruth S. Hermansson, Remi A. Nout, Paul Martin Putora, Ludwig Plasswilm, Nikolaos Tselis

Summary: This study analysed decision criteria and techniques for adjuvant brachytherapy among European radiation oncology experts. The results showed that there was a clear trend towards adjuvant brachytherapy for certain stages and types of endometrial cancer. There were also variations in dose prescription and techniques used. Some experts already incorporated molecular markers into their decision-making process.

CANCERS (2022)

Add to Collection

Review Oncology

Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies

Yuedan Zhou, Elie Rassy, Alexandre Coutte, Samir Achkar, Sophie Espenel, Catherine Genestie, Patricia Pautier, Philippe Morice, Sebastien Gouy, Cyrus Chargari

Summary: Cervical cancer, caused by human papillomavirus infection, remains a leading cause of cancer death in women in low- and middle-income countries. The main treatments for early-stage cervical cancer are upfront surgery, while concurrent chemoradiotherapy is the standard care for locally advanced cervical cancer. Ongoing research is evaluating the use of immunotherapy in locally advanced tumors.

CANCERS (2022)

Add to Collection

Article Oncology

Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France

Rita Bentahila, Elie Rassy, Samir Achkar, Florence Sacino, Stefanos Bougas, Alexis Vallard, Vincent Vinh-Hung, Johan Encaoua, Pierre Gustin, Sylvie Mengue, Patricia Pautier, Philippe Morice, Sebastien Gouy, Sophie Espenel, Eric Deutsch, Cyrus Chargari

Summary: This retrospective study reports the experience of a referral network for women with locally advanced cervical cancer (LACC) who require image-guided adaptive brachytherapy (IGABT). The study demonstrates the feasibility of the referral process, but highlights the need for well-defined workflows and appropriate resource allocation to minimize overall treatment time for this advanced technique.

CANCERS (2022)

Add to Collection

Article Oncology

Implementation of Image-Guided Brachytherapy for Pediatric Vaginal Cancers: Feasibility and Early Clinical Results

Mario Terlizzi, Veronique Minard, Christine Haie-Meder, Sophie Espenel, Helene Martelli, Florent Guerin, Cyrus Chargari

Summary: This study examines the experience of using pulsed dose rate brachytherapy for the treatment of pediatric vaginal tumors. The results show that this treatment method has good compliance, excellent local control, and low toxicity rates. Due to the rarity of the disease and the technical aspects of treatment in young patients, referral to specialized centers is recommended.

CANCERS (2022)

Add to Collection

Review Oncology

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside

Stergios Boussios, Elie Rassy, Michele Moschetta, Aruni Ghose, Sola Adeleke, Elisabet Sanchez, Matin Sheriff, Cyrus Chargari, Nicholas Pavlidis

Summary: DNA damage is a hallmark of cancer. Epithelial ovarian cancer (EOC) and prostate cancer often have defects in DNA damage response (DDR) pathways. PARP inhibitors are a therapeutic strategy for EOC and prostate cancer, particularly in tumors with HR deficiency. Genetic testing plays an increasingly important role in the treatment of ovarian and prostate cancer patients.

CANCERS (2022)

Add to Collection

Article Biology

Two New Potential Therapeutic Approaches in Radiation Cystitis Derived from Mesenchymal Stem Cells: Extracellular Vesicles and Conditioned Medium

Carole Helissey, Nathalie Guitard, Helene Thery, Sylvie Goulinet, Philippe Mauduit, Maria Girleanu, Anne-Laure Favier, Michel Drouet, Charles Parnot, Cyrus Chargari, Sophie Cavallero, Sabine Francois

Summary: Pelvic radiotherapy is an important treatment for pelvic tumors, but it can cause symptoms that affect patients' quality of life. Despite improvements in radiation techniques, radiation cystitis remains stable and treatment options are limited. Mesenchymal stromal cells (MSC) have shown promise in promoting tissue repair through the release of extracellular vesicles (MSC-EVs) or conditioned medium (MSC-CM). In vitro experiments have demonstrated the potential of MSC-EVs and MSC-CM in preventing fibrosis in radiation cystitis models.

BIOLOGY-BASEL (2022)

Add to Collection

Article Medicine, General & Internal

Management of Endometrial Cancer: French Society of Onco-Gynecology's Evaluation through a Delphi Survey

Carolin Marti, Elise Deluche, Floriane Jochum, Sofiane Bendifallah, Henri Azais, Jonas Deidier, Vincent Cockenpot, Ines Menoux, Vincent Balaya, Sarah Betrian, Cyrus Chargari, Sebastien Gouy, Catherine Genestie, Anis Feki, Catherine Uzan, Frederic Guyon, Mojgan Devouassoux-Shisheboran, Noemie Body, Cherif Akladios, Patrice Mathevet, Benedetta Guani

Summary: The study aimed to evaluate the opinion and achieve a consensus among a panel of experts on the management of endometrial cancer in France and French Switzerland. A Delphi survey was conducted, and the experts were asked to answer questionnaires to determine their views on various aspects of endometrial cancer management. The findings provide valuable recommendations for standardizing the management of endometrial cancer and improving clinical practices.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Review Oncology

Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma

Sheila Terwisscha van Scheltinga, Timothy Rogers, Naima Smeulders, Federica deCorti, Florent Guerin, Ross Craigie, Gabriela Guillen Burrieza, Ludi Smeele, Marinka Hol, Rick van Rijn, Joerg Fuchs, Guido Seitz, Andreas Schmidt, Beate Timmermann, Per-Ulf Tunn, Cyrus Chargari, Raquel Davila Fajardo, Olga Slater, Jenny Gains, Hans Merks

Summary: This review discusses the developments in staging and local treatment strategies for specific sites of rhabdomyosarcoma tumors, including head and neck, chest/trunk, bladder-prostate, female genito-urinary, perianal, and extremity sites. It also focuses on the treatment strategies for very young patients, as well as those with metastatic or relapsed disease. Specific surgical techniques such as whole limb perfusion, HIPEC, and fluorescence guided surgery are also addressed. The goal of these innovations is to improve loco-regional control of the disease while minimizing treatment morbidity.

CANCERS (2023)

Add to Collection

Article Oncology

Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation

Lydia Meziani, Marine Gerbe de Thore, Celine Clemenson, Winchygn Liu, Pierre-Antoine Laurent, Michele Mondini, Marie-Catherine Vozenin, Eric Deutsch

Summary: CD73 targeting can improve the antitumor effects of irradiation and immune checkpoint inhibitor treatment, and the dosing regimen and iCOS expression are important factors that affect the therapeutic efficacy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Add to Collection

Proceedings Paper Computer Science, Artificial Intelligence

Automatic Brain Tumor Segmentation with a Bridge-Unet Deeply Supervised Enhanced with Downsampling Pooling Combination, Atrous Spatial Pyramid Pooling, Squeeze-and-Excitation and EvoNorm

Alexandre Carre, Eric Deutsch, Charlotte Robert

Summary: Segmentation of brain tumors is a critical task for disease management. The Multimodal Brain Tumor Segmentation Challenge provides a platform to compare automatic segmentation algorithms. This year, the challenge has expanded in scale. Researchers developed a network model based on Bridge-Unet and incorporated various improvements, achieving good segmentation performance.

BRAINLESION: GLIOMA, MULTIPLE SCLEROSIS, STROKE AND TRAUMATIC BRAIN INJURIES, BRAINLES 2021, PT II (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.